Literature DB >> 11344243

Estrogen receptors alpha and beta are differentially expressed in developing human bone.

S Bord1, A Horner, S Beavan, J Compston.   

Abstract

Estrogen plays an essential role in the development and maintenance of the skeleton; its effects are mediated via interactions with two estrogen receptor (ER) subtypes, alpha and beta. The aim of this study was to establish the cellular distribution of ERalpha and ERbeta in neonatal human rib bone. ERalpha and ERbeta immunoreactivity was seen in proliferative and prehypertrophic chondrocytes in the growth plate, with lower levels of expression in the late hypertrophic zone. Different patterns of expression of the two ERs were seen in bone. In cortical bone, intense staining for ERalpha was observed in osteoblasts and osteocytes adjacent to the periosteal-forming surface and in osteoclasts on the opposing resorbing surface. In cancellous bone, ERbeta was strongly expressed in both osteoblasts and osteocytes, whereas only low expression of ERalpha was seen in these areas. Nuclear and cytoplasmic staining for ERbeta was apparent in osteoclasts. These observations demonstrate distinct patterns of expression for the two ER subtypes in developing human bone and indicate functions in both the growth plate and mineralized bone. In the latter, ERalpha is predominantly expressed in cortical bone, whereas ERbeta shows higher levels of expression in cancellous bone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344243     DOI: 10.1210/jcem.86.5.7513

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  78 in total

1.  Peak bone mineral density at the hip is linked to chromosomes 14q and 15q.

Authors:  Munro Peacock; Daniel L Koller; Siu Hui; C Conrad Johnston; Tatiana Foroud; Michael J Econs
Journal:  Osteoporos Int       Date:  2004-03-16       Impact factor: 4.507

2.  Gender- and region-specific variations of estrogen receptor α and β expression in the growth plate of spine and limb during development and adulthood.

Authors:  Xin-Feng Li; Shan-Jin Wang; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Histochem Cell Biol       Date:  2011-11-06       Impact factor: 4.304

3.  Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women.

Authors:  Shoji Ichikawa; Daniel L Koller; Munro Peacock; Michelle L Johnson; Dongbing Lai; Siu L Hui; C Conrad Johnston; Tatiana M Foroud; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

Review 4.  Craniofacial tissue engineering by stem cells.

Authors:  J J Mao; W V Giannobile; J A Helms; S J Hollister; P H Krebsbach; M T Longaker; S Shi
Journal:  J Dent Res       Date:  2006-11       Impact factor: 6.116

Review 5.  Regulation of Bone Metabolism by Sex Steroids.

Authors:  Sundeep Khosla; David G Monroe
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

Review 6.  Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

Authors:  J R Hawse; M Subramaniam; J N Ingle; M J Oursler; N M Rajamannan; T C Spelsberg
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

Review 7.  Isoflavones and skeletal health: are these molecules ready for clinical application?

Authors:  S Migliaccio; J J B Anderson
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

Review 8.  Androgens and bone.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Steroids       Date:  2008-10-17       Impact factor: 2.668

9.  Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men.

Authors:  Sundeep Khosla
Journal:  Bone       Date:  2008-05-16       Impact factor: 4.398

Review 10.  Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity.

Authors:  Eric P Smith; Bonny Specker; Kenneth S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-10       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.